Schedule 13G ownership disclosure

CATALYST PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 14888U101

Event date: 2019-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,131,683
Percent of class
11.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-19-001021
Form type
SC 13G/A
Filer
CATALYST PHARMACEUTICALS, INC.
CIK
CIK 1369568
Filed
Mar 06, 2019
Reporting period
Feb 28, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub